Evaluation on the effect of Chushifangyi prescription in preventing novel coronavirus pneumonia (COVID-19)
Not Applicable
Recruiting
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2000003124
- Lead Sponsor
- The affiliated Hospital to Changchun University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Vulnerable and high risk groups such as health care workers and non health care workers in health care settings. 2019-ncov.
Exclusion Criteria
1. A pregnant or lactating woman;
2. With other major diseases, such as serious heart, lung, liver, kidney damage or psychiatric patients. Participants should not take part in the study under any of the above circumstances. The Research Hospital and the applicant unit will not bear the responsibility if they intentionally conceal the medical history and medication history.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Confirmed 2019-ncov pneumonia;
- Secondary Outcome Measures
Name Time Method Fatigue Scale-14 (FS-14);Symptom Scale of Traditional Chinese Medicine;